Knight Therapeutics Inc T.GUD

Alternate Symbol(s): KHTRF

Healthcare

Knight Therapeutics Inc. is a specialty pharmaceutical company. The Company’s principal business activity is developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select international markets. The Company invests in life sciences venture capital funds whereby the Company may receive preferential access to healthcare products for Canada and select international markets. It develops pharmaceutical products, including those to treat neglected tropical and rare pediatric diseases. The portfolio consists of pharmaceutical products with molecules and includes both in-licensed products such as Lenvima, Cresemba, Halaven, Trelstar, Akynzeo, Ambisome, Minjuvi, Imvexxy as well as products owned by Knight such as Exelon and Impavido.

TSX:GUD - Post by User

Knight Therapeutics Inc

Bullboard Posts

Comment by wagyusteakon Nov 13, 2020 1:06pm

96 Views

Post# 31895920

RE:RE:RE:RE:RE:RE:RE:RE:Does anyone sell today?? Let me buy your shares @ $1-$3

Benedict16th wrote: 20 Years investment is the past strategies, because of AI and genomics unlike the past many companies will not be around in twenty Years. GUD MNGT in six Years have miserably failed to obtain meaningful rights to new drugs. The old strategies to get new drug rights on the cheap no longer work. The market knows but GUD MNGT do not seem to know. The exit door for this MNGT is getting closer. Only a new MNGT with new ideas and strategies can rescue this company from the current mngt. Yes Meir called correct

hahahahahhaha.

Bullboard Posts

Sony’s Alpha 1 II: A new professional photography standard?